These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 32942999

  • 1. Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study.
    Yebyo HG, Zappacosta S, Aschmann HE, Haile SR, Puhan MA.
    BMC Cardiovasc Disord; 2020 Sep 17; 20(1):418. PubMed ID: 32942999
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study.
    Yebyo HG, Aschmann HE, Puhan MA.
    Ann Intern Med; 2019 Jan 01; 170(1):1-10. PubMed ID: 30508425
    [Abstract] [Full Text] [Related]

  • 4. Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts.
    Yebyo HG, Aschmann HE, Yu T, Puhan MA.
    BMC Cardiovasc Disord; 2018 May 18; 18(1):97. PubMed ID: 29776337
    [Abstract] [Full Text] [Related]

  • 5. Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit-harm balance modeling study.
    Yebyo HG, Aschmann HE, Menges D, Boyd CM, Puhan MA.
    Ther Adv Chronic Dis; 2019 May 18; 10():2040622319877745. PubMed ID: 31598209
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.
    US Preventive Services Task Force, Mangione CM, Barry MJ, Nicholson WK, Cabana M, Chelmow D, Coker TR, Davis EM, Donahue KE, Jaén CR, Kubik M, Li L, Ogedegbe G, Pbert L, Ruiz JM, Stevermer J, Wong JB.
    JAMA; 2022 Aug 23; 328(8):746-753. PubMed ID: 35997723
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetes.
    Morieri ML, Perrone V, Veronesi C, Degli Esposti L, Andretta M, Plebani M, Fadini GP, Vigili de Kreutzenberg S, Avogaro A.
    Cardiovasc Diabetol; 2021 Jul 16; 20(1):144. PubMed ID: 34271920
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Statins in the primary and secondary prevention of cardiovascular disease in women: facts and myths.
    Virani SS.
    Tex Heart Inst J; 2013 Jul 16; 40(3):288-9. PubMed ID: 23914021
    [No Abstract] [Full Text] [Related]

  • 19. Comparing Guidelines for Statin Treatment in Canada and the United States.
    Hennessy DA, Bushnik T, Manuel DG, Anderson TJ.
    J Am Heart Assoc; 2015 Jul 14; 4(7):. PubMed ID: 26175357
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.